McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Health Tech Faves & Investment Trends from Innovation Insiders

by McKesson Ventures | Jun 28, 2021 | Media Coverage

McKesson Ventures Partner Michelle Snyder was one of the speakers at a recent HLTH webinar on investment trends in the health tech field. The webinar, held June 24, 2021, also featured Keith Figloli, general partner at LVRHealth; and Anne Wellington, managing director...

Key Advances in Precision Medicine in Lung Cancer

by McKesson Ventures | May 10, 2021 | Media Coverage

US Oncology Research, supported by McKesson and the US Oncology Network, has a network of experienced and dedicated clinical staff and investigators who specialize in Phase I through Phase IV clinical trials. Robert Coleman, MD, FACOG, FACS, serves as its Chief...

Alula Creates DTC Marketplace for Cancer Patients

by McKesson Ventures | Apr 30, 2021 | Media Coverage

Alula, McKesson’s first digital cancer treatment marketplace partner, opened up its DTC marketplace in April. The purpose? Make it easier for cancer patients to find and purchase the products they need at any given stage of their treatment. Liya Shuster-Bier was a...

Michelle Snyder Brings a Creative Spirit to Marketing and Investing

by McKesson Ventures | Apr 27, 2021 | Media Coverage

Michelle Snyder is McKesson Ventures’ newest partner, having joined the firm in late 2020. But Snyder is a digital health veteran and she’s seen innovation in the industry from every angle, from marketing to mentoring to investing. In a recent StartUp Health Fireside...

Covid-19 serves as catalyst for effort to diversity clinical trial enrollment

by McKesson Ventures | Apr 23, 2021 | Media Coverage

McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...

McKesson Ventures highlights investment priorities amidst a trail of successful exits

by McKesson Ventures | Apr 20, 2021 | Media Coverage

In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in...
Page 3 of 10«12345...10...»Last »

Recent Posts

  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
  • Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
  • BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
  • Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings